Junko Yabuuchi

1PUBLICATIONS
4CO-AUTHORS
Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 17, 2023
Safety and effectiveness of empagliflozin in clinical practice as monotherapy or with other glucose-lowering drugs in Japanese patients with type 2 diabetes: subgroup analysis of a 3-year post-marketing surveillance study.

Kohei Kaku, Yayoi Nakayama, Junko Yabuuchi

Pageof 1

Frequent Collaborators

1 joint publications

Kohei Kaku

1 joint publications

Yayoi Nakayama

1 joint publications

Yusuke Naito

1 joint publications

Keizo Kanasaki